Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

942.55

3.35 (0.36%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Zydus Lifesciences informs about press release

>>

Zydus Lifesciences’ arm receives USFDA’s acceptance for CUTX-101 NDA resubmission

>>

Zydus Lifesciences launches Denosumab biosimilar ‘Zyrifa’

>>

Zydus Lifesciences jumps as its arm joins hands with Formycon AG for biosimilar of Keytruda

>>

Zydus Lifesciences’ arm joins hands with Formycon AG for biosimilar of Keytruda

>>

Zydus Lifesciences gets EIR from USFDA for Jarod injectable facility

>>

Zydus Lifesciences rises on getting USFDA’s tentative nod for Empagliflozin and Linagliptin Tablets

>>

Zydus Lifesciences gets USFDA’s tentative nod for Empagliflozin and Linagliptin Tablets

>>

Zydus Lifesciences informs about press release

>>

Zydus Lifesciences inks exclusive licensing and commercialization pact with RK Pharma Inc

<< < 5 6 7 ...168 > >>